MedPath

Study the effect of subcutaneous injection of naloxone to prevent pruritus caused of intrathecal injection of pethidine in minor surgeries

Phase 2
Conditions
itching.
Irritant contact dermatitis, unspecified cause
Registration Number
IRCT2017021210222N8
Lead Sponsor
Vice chancellor for research of Shahrekord University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
105
Inclusion Criteria

patients condidate spinal anesthesia using exclusion criteria: the creation of any side effects of naloxone any cardiovascular disease; Addiction to opioids

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Itching. Timepoint: after surgery. Method of measurement: checklist.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath